POLLASTRI, SARA
POLLASTRI, SARA
Dipartimento di Scienze per gli Alimenti, la Nutrizione e l'Ambiente
Increasing the Chemical Space of L-SIGN Specific Glycomimetics
2025 G. Cavazzoli, C. Delaunay, S. Pollastri, A. Panzeri, S. Sattin, M. Thépaut, L. Belvisi, F. Fieschi, A. Bernardi
Targeting L-SIGN: a potential tool against SARS-CoV-2
2024 G. Cavazzoli, S. Pollastri, C. Delaunay, M. Thepaut, F. Fieschi, A. Bernardi
Polyvalent Glycomimetic-Gold Nanoparticles Revealing Critical Roles of Glycan Display on Multivalent Lectin–Glycan Interaction Biophysics and Antiviral Properties
2024 X. Ning, D. Budhadev, S. Pollastri, I. Nehlmeier, A. Kempf, I. Manfield, W.B. Turnbull, S. Pöhlmann, A. Bernardi, X. Li, Y. Guo, D. Zhou
Polyvalent Glycomimetic-Gold Nanoparticle Conjugates reveal effects of glycan display on Multivalent Lectin-Glycan Interactions
2024 X. Ning, D. Budhadev, S. Pollastri, I. Nehlmeier, A. Kempf, I. Manfield, B. Turnbull, S. Pöhlmann, A. Bernardi, X. Li, Y. Guo, D. Zhou
Unprecedented selectivity for homologous lectin targets: differential targeting of the viral receptors L-SIGN and DC-SIGN
2024 C. Delaunay, S. Pollastri, M. Thépaut, G. Cavazzoli, L. Belvisi, C. Bouchikri, N. Labiod, F. Lasala, A. Gimeno, A. Franconetti, J. Jiménez-Barbero, A. Ardá, R. Delgado, A. Bernardi, F. Fieschi
Glycomimetic ligands acting as selective antagonists of L-SIGN
2023 G. Cavazzoli, S. Pollastri, C. Delaunay, F. Fieschi, A. Bernardi
Mannose-based glycomimetics acting as selective ligands for L-SIGN
2023 G. Cavazzoli, S. Pollastri, C. Delaunay, F. Fieschi, A. Bernardi
SELECTIVE GLYCOMIMETIC LIGANDS OF C-TYPE LECTIN RECEPTORS
2023 S. Pollastri
Development of a highly selective glycomimetic ligand for L-SIGN: a new tool against SARS-CoV-2 and Ebola viruses
2023 C. Delaunay, S. Pollastri, M. Thépaut, G. Cavazzoli, L. Belvisi, C. Bouchikri, N. Labiod, A. Gimeno, A. Franconetti, J. Jiménez-Barbero, A. Ardá, R. Delgado, A. Bernardi, F. Fieschi
Man-based glycomimetics inhibit DC/L-SIGN interaction with SARS-CoV-2 spike protein
2022 S. Pollastri, C. Delaunay, M. Thépaut, F. Fieschi, A. Bernardi
Exploiting DNA Ligase III addiction of multiple myeloma by flavonoid Rhamnetin
2022 D. Caracciolo, G. Juli, C. Riillo, A. Coricello, F. Vasile, S. Pollastri, R. Rocca, F. Scionti, N. Polerà, K. Grillone, M. Arbitrio, N. Staropoli, B. Caparello, D. Britti, G. Loprete, G. Costa, M.T. Di Martino, S. Alcaro, P. Tagliaferri, P. Tassone
C2-Triazole-modified mannose-based L-SIGN antagonists
2022 S. Pollastri, C. Delaunay, M. Thépaut, F. Fieschi, A. Bernardi
Glycomimetic ligands block the interaction of SARS-CoV-2 spike protein with C-type lectin co-receptors
2022 S. Pollastri, C. Delaunay, M. Thepaut, F. Fieschi, A. Bernardi
Structural simplification of ps-diMan based glycomimetics as DC-SIGN antagonists
2021 S. Pollastri, C. Delaunay, C. Vivès, M. Thépaut, F. Fieschi, A. Bernardi